SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mercury Laboratories

BSE: 538964 29 Sep 2025
Healthcare
₹ 857.5
Mercury Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Mercury Laboratories - Share Price & Details

Market Cap
₹98.2
High /Low
1,190 / 736.0
Stock P/E
26.1
Book Value
₹446.0
Dividend Yield
0.43
ROCE
8.94
ROE
₹5.94
Face Value
10.0
PEG Ratio
-7.45
EVEBITDA
₹11.4
Debt
5.45
CMP / FCF
-174.0
Debt to equity
₹0.1
NP Ann
3.14
High price all time
1,303
Piotroski score
₹5.0
Graham Number
562.0
No. Eq. Shares
0.12
Net CF
₹-6.03
Net profit
3.77
Price to book value
1.83
Interest Coverage
₹10.5
Low price all time
32.5
Industry PE
33.0
Reserves
₹52.4
Free Cash Flow
₹-5.04

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Mercury Laboratories LimitedNANANANA98.226.1
Rajnish Wellness LimitedNANANANA97.5886.0
IND-SWIFT LTD.NANANANA94.51.47

Peer Comparison Chart


About Mercury Laboratories

Mercury Laboratories Limited, with Security Code 538964, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Independent labs have found Alexei Navalny was poisoned, widow says

(18 Sep 2025)
Russian opposition leader Mr Navalny campaigned against official corruption and staged massive anti-Kremlin protests.
Read more →

Is Alliance Resource Partners L.P. Limited Partnership stock overvalued or undervalued - Maximize gains with proven stock analysis

(16 Aug 2025)
【Market Discussions】✌️ Our team has a proven track record of predicting multi-bagger stocks — now it's your turn to benefit.
Read more →

Coal India, Dr Lal PathLabs, Ramco Cements, Blue Dart to turn ex-dividend on Wednesday

(16 Aug 2025)
The Coal India board, at its meeting held on July 31, had recommended an interim dividend of Rs 5.5 per equity share.
Read more →

Mercury Laboratories Reports Mixed Financial Results Amid Liquidity Concerns in August 2025

(11 Aug 2025)
Mercury Laboratories has reported its financial results for the quarter ending June 2025, showcasing a peak in operating profit and margin,...
Read more →

Mercury Laboratories standalone net profit rises 185.29% in the June 2025 quarter

(11 Aug 2025)
Net profit of Mercury Laboratories rose 185.29% to Rs 0.97 crore in the quarter ended June 2025 as against Rs 0.34 crore during the previous...
Read more →

Mercury Laboratories Limited (538964) to Launch New Product Line - Free Popular Stock Recommendations

(06 Aug 2025)
Mercury Laboratories Limited (538964) to Launch New Product Line ✌️【Market Sentiment】✌️ Stock group insights to identify profitable stocks...
Read more →